Biomerica Inc (BMRA) Price to Earnings Ratio

Corporate emblem and logo of Biomerica, Inc (BMRA)

The market for gastrointestinal pathology diagnostic systems is growing actively, providing Biomerica, Inc. (BMRA) with a steady stream of orders from US clinics. The business relies on low dependence on economic cycles, although its small capitalization creates certain risks. The price action of securities with the -1.20 indicator confirms the company's status as a trusted expert in metabolic testing, developing precise methods for determining food intolerances.

BMRA Biomerica: Price to Earnings Ratio in the range 07/04/2022 - 11/16/2026

Analytical breakdowns for Biomerica, Inc.

- price and consensus price forecast:
Summary company analysis:Biomerica
Manufactured product of Biomerica, Inc.

Systematic asset selection requires rigorous filtering of market noise to exclude overvalued securities. The P/E ratio measures the cost per unit of profit, determining the payback period for investments based on current earnings. For Biomerica, Inc. (BMRA), this metric reflects the efficiency of its production outsourcing and IT infrastructure model. Cost optimization via contract manufacturing sites directly impacts net income. By analyzing the company's average P/E, an investor assesses the fundamental fairness of the market price.

Key competitors

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|Nordion (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Health Inc|CareDx (CDNA) - Business Payback Period|Price to Earnings Ratio Maravai LifeSciences Holdings (MRVI)|FLGT: Market Cap to Net Income|P/E Multiple LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Market Cap to Earnings|OraSure Corp - P/E Multiple|Market Cap to Net Income Ratio exagen.com (XGN)|MDXH: P/E Multiple|LUCD - Business Payback Period|Price to Earnings Ratio PRE|IMDX - Market Cap to Net Income Ratio|Price to Earnings Ratio TRIB (Trinity Biotech plc)|P/E Multiple prophaselabs.com (PRPH)|P/E Multiple AIMD (Ainos Inc)|Market Cap to Net Income Ratio Co-Diagnostics Inc|heartsciences.com - P/E Multiple|CDIO (cardiodiagnosticsinc.com) - Price to Earnings Multiple|ONCO (Onconetix) - Price to Earnings Ratio|Market Cap to Earnings viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple